Sage Journals: Discover world-class research

Abstract

Participants in placebo-controlled clinical trials give informed consent to be randomized to verum or placebo. However, researchers rarely tell participants which treatment they actually received. We interviewed 4 participants in a trial of acupuncture for irritable bowel syndrome before, during, and after they received a course of placebo treatments over 6 weeks. During the final interview, we informed participants that they had received a course of placebo treatments. We used an idiographic phenomenological approach based on the Sheffield School to describe each participant’s experiences of being blinded to and then debriefed to placebo allocation. The participants’ experiences of blinding and debriefing were embodied, related to their goals in undertaking the study, and social (e.g., embedded in trusting and valued relationships with acupuncturists). We suggest ways in which debriefing to placebo allocation can be managed sensitively to facilitate positive outcomes for participants.

Keywords

ethics / moral perspectives Giorgi health care alternative and complementary interviews,semistructured phenomenology research participation research,quantitative

Get full access to this article

View all access options for this article.

References

Appelbaum

P. S.

Roth

L. H.

Lidz

C. W.

Benson

Winslade

(1987). False hopes and best data—Consent to research and the therapeutic misconception. Hastings Center Report, 17(2), 20-24.

Ashworth

(2003). The lifeworld as phenomenon and as research heuristic, exemplified by a study of the lifeworld of a person suffering Alzheimer’s disease. Journal of Phenomenological Psychology, 34(2), 179-205. doi:10.1163/15691620332284713710.1163/156916203322847137

Ashworth

(2003). An approach to phenomenological psychology: The contingencies of the lifeworld. Journal of Phenomenological Psychology, 34(2), 145-156. doi:10.1163/15691620332284711910.1163/156916203322847119

Ashworth

Freewood

Macdonald

(2003). The student lifeworld and the meanings of plagiarism. Journal of Phenomenological Psychology, 34(2), 257-278. doi:10.1163/15691620332284716410.1163/156916203322847164

Avins

Bent

Padula

Staccone

Badua

Goldberg

(2008). Initial experience with a group presentation of study results to research participants. Trials, 9(1), 16. doi:10.1186/1745-6215-9-1610.1186/1745-6215-9-16

Beskow

L. M.

Burke

Merz

J. F.

Barr

P. A.

Terry

Penchaszadeh

V. B.

. . . Khoury

M. J.

(2001). Informed consent for population-based research involving genetics. Journal of the American Medical Association, 286(18), 2315-2321. doi:10.1001/jama.286.18.231510.1001/jama.286.18.2315

Buchwald

Fitch

L. L.

Matts

J. P.

Johnson

J. W.

Hansen

B. J.

Stuenkel

M. R.

Brooks

H. B.

(1993). Perception of quality of life before and after disclosure of trial results: A report from the Program on the Surgical Control of the Hyperlipidemias (POSCH). Controlled Clinical Trials, 14(6), 500-510. doi:10.1016/0197-2456(93)90030-H10.1016/0197-2456(93)90030-H

Bylund

C. L.

Gueguen

J. A.

Sabee

C. M.

Imes

R. S.

Aldridge Sanford

(2007). Provider-patient dialogue about Internet health information: An exploration of strategies to improve the provider-patient relationship. Patient Education and Counseling, 66, 346-352. doi:10.1016/j.pec.2007.01.00910.1016/j.pec.2007.01.009

Chung

S. K.

Price

D. D.

Verne

G. N.

Robinson

M. E.

(2007). Revelation of a personal placebo response: Its effects on mood, attitudes and future placebo responding. Pain, 132(3), 281-288. doi:10.1016/j.pain.2007.01.03410.1016/j.pain.2007.01.034

10.

Department of Health. (2005). Research governance framework for health and social care (2nd ed.). London: Department of Health. Retrieved from http://www.dh.gov.uk

11.

Di Blasi

Crawford

Bradley

Kleijnen

(2005). Reactions to treatment debriefing among the participants of a placebo controlled trial. BMC Health Services Research, 5, 30. doi:10.1186/1472-6963-5-3010.1186/1472-6963-5-30

12.

Di Blasi

Kaptchuk

T. J.

Weinman

Kleijnen

(2002). Informing participants of allocation to placebo at trial closure: Postal survey. British Medical Journal, 325(7376), 1329. Retrieved from http://www.bmj.com/cgi/content/abstract/325/7376/1329

13.

Dinnett

E. M.

Mungall

M. M.

Kent

J. A.

Ronald

E. S.

McIntyre

K. E.

Anderson

Gaw

(2005). Unblinding of trial participants to their treatment allocation: Lessons from the Prospective Study of Pravastatin in the Elderly at Risk (PROSPER). Clinical Trials, 2(3), 254-259. doi:10.1191/1740774505cn089oa10.1191/1740774505cn089oa

14.

Dixon-Woods

Jackson

Windridge

K. C.

Kenyon

(2006). Receiving a summary of the results of a trial: Qualitative study of participants’ views. British Medical Journal, 332(7535), 206-209. doi:10.1136/bmj.38675.677963.3A10.1136/bmj.38675.677963.3A

15.

Evans

B. W.

Clark

W. K.

Moore

D. J.

Whorwell

P. J.

(2007). Tegaserod for the treatment of irritable bowel syndrome and chronic constipation. Cochrane Database of Systematic Reviews, 4, CD003960. doi:10.1002/14651858.CD003960.pub310.1002/14651858.CD003960.pub3

16.

Fergusson

Glass

K. C.

Waring

Shapiro

(2004). Turning a blind eye: The success of blinding reported in a random sample of randomised, placebo controlled trials. British Medical Journal, 328(7437), 432. doi:10.1136/bmj.328.74327.37952.631667.EE10.1136/bmj.328.74327.37952.631667.EE

17.

Gearing

R. E.

(2004). Bracketing in research: A typology. Qualitative Health Research, 14, 1429-1452. doi:10.1177/104973230427039410.1177/1049732304270394

18.

Giorgi

(1985). Sketch of a psychological phenomenological method. In Giorgi

(Ed.), Phenomenology and psychological research (pp. 8-22). Pittsburgh, PA: Duquesne University Press.

19.

Goetz

C. G.

Janko

Blasucci

Jaglin

J. A.

(2003). Impact of placebo assignment in clinical trials of Parkinson’s disease. Movement Disorders, 18(10), 1146-1149. doi:10.1002/mds.1050410.1002/mds.10504

20.

Goffman

(1967). Interaction ritual: Essays on face-to-face behavior. Garden City, NY: Anchor Books.

21.

Håkanson

Sahlberg-Blom

Ternestedt

B.-M.

(2010). Being in the patient position: Experiences of health care among people with irritable bowel syndrome. Qualitative Health Research, 20, 1116-1127. doi:10.1177/104973231036991410.1177/1049732310369914

22.

Hochman

McCormick

(2010). Characteristics of published comparative effectiveness studies of medications. Journal of the American Medical Association, 303(10), 951-958. doi:10.1001/jama.2010.24010.1001/jama.2010.240

23.

Kaptchuk

T. J.

Kelley

J. M.

Conboy

L. A.

Davis

R. B.

Kerr

C. E.

Jacobsen

E. E.

. . . Lembo

A. J.

(2008). Components of placebo effect: Randomised controlled trial in patients with irritable bowel syndrome. British Medical Journal, 336, 999-1003. doi:10.1136/bmj.39524.439618.2510.1136/bmj.39524.439618.25

24.

Kaptchuk

T. J.

Shaw

Kerr

C. E.

Conboy

L. A.

Kelley

J. M.

Csordas

T. J.

. . . Jacobsen

E. E.

(2009). “Maybe I made up the whole thing”: Placebos and patients’ experiences in a randomized controlled trial. Culture Medicine and Psychiatry, 33, 382-411. doi:10.1007/s11013-009-9141-710.1007/s11013-009-9141-7

25.

Lacy

B. E.

Weiser

Noddin

Robertson

D. J.

Crowell

M. D.

Parratt-Engstrom

Grau

M. V.

(2007). Irritable bowel syndrome: Patients’ attitudes, concerns and level of knowledge. Alimentary Pharmacology & Therapeutics, 25(11), 1329-1341. doi:10.1111/j.1365-2036.2007.03328.x10.1111/j.1365-2036.2007.03328.x

26.

Langdridge

(2007). Phenomenological psychology. Theory, research and method. Harlow, UK: Pearson Prentice Hall.

27.

Leventhal

H. A.

Brissette

Leventhal

E. A.

(2003). The common-sense model of self-regulation of health and illness. In Cameron

L. D.

Leventhal

(Eds.), The self-regulation of health and illness behaviour (pp. 42-65). London: Routledge.

28.

Miller

F. G.

Kaptchuk

T. J.

(2004). Sham procedures and the ethics of clinical trials. Journal of the Royal Society of Medicine, 97(12), 576-578. Retrieved from http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1079669/pdf/00970576.pdf

29.

Naldi

Svensson

Zenoni

Diepgen

Elsner

Grob

J.-J.

. . . Williams

(2010). Comparators, study duration, outcome measures and sponsorship in therapeutic trials of psoriasis: Update of the EDEN Psoriasis Survey 2001–2006. British Journal of Dermatology, 162(2), 384-389. doi:10.1111/j.1365-2133.2009.09515.x10.1111/j.1365-2133.2009.09515.x

30.

Pollock

(2007). Maintaining face in the presentation of depression: Constraining the therapeutic potential of the consultation. Health: An Interdisciplinary Journal for the Social Study of Health, Illness and Medicine, 11(2), 163-180. doi:10.1177/136345930707469210.1177/1363459307074692

31.

Potter

(1996). Representing reality: Discourse, rhetoric and social construction. London: Sage.

32.

Richards

M. P. M.

Ponder

Pharoah

Everest

Mackay

(2003). Issues of consent and feedback in a genetic epidemiological study of women with breast cancer. Journal of Medical Ethics, 29(2), 93-96. doi:10.1136/jme.29.2.9310.1136/jme.29.2.93

33.

Riedl

Maass

Fliege

Stengel

Schmidtmann

Klapp

B. F.

Mönnikes

(2009). Subjective theories of illness and clinical and psychological outcomes in patients with irritable bowel syndrome. Journal of Psychosomatic Research, 67(5), 449-455. doi:10.1016/j.jpsychores.2009.02.00110.1016/j.jpsychores.2009.02.001

34.

Rutter

C. L.

Rutter

D. R.

(2002). Illness representation, coping and outcome in irritable bowel syndrome (IBS). British Journal of Health Psychology, 7, 377-391. doi:10.1348/13591070232064537210.1348/135910702320645372

35.

Rutter

C. L.

Rutter

D. R.

(2007). Longitudinal analysis of the illness representation model in patients with irritable bowel syndrome (IBS). Journal of Health Psychology, 12(1), 141-148. doi:10.1177/135910530707174810.1177/1359105307071748

36.

Sandler

Glesne

Geller

(2008). Children’s and parents’ perspectives on open-label use of placebos in the treatment of ADHD. Child: Care, Health and Development, 34(1), 111-120. doi:10.1111/j.1365-2214.2007.00743.x10.1111/j.1365-2214.2007.00743.x

37.

Shalowitz

D. I.

Miller

F. G.

(2005). Disclosing individual results of clinical research: Implications of respect for participants. Journal of the American Medical Association, 294(6), 737-740. doi:10.1001/jama.294.6.73710.1001/jama.294.6.737

38.

Shalowitz

D. I.

Miller

F. G.

(2008). Communicating the results of clinical research to participants: Attitudes, practices, and future directions. PLoS Medicine, 5(5), e91. doi:10.1371/journal.pmed.005009110.1371/journal.pmed.0050091

39.

Stang

Hense

H.-W.

Jöckel

K.-H.

Turner

E. H.

Tramèr

M. R.

(2005). Is it always unethical to use a placebo in a clinical trial? PLoS Medicine, 2(3), e72. doi:10.1371/journal.pmed.002007210.1371/journal.pmed.0020072

40.

Streitberger

Kleinhenz

(1998). Introducing a placebo needle into acupuncture research. Lancet, 352(9125), 364-365. doi:10.1016/S0140-6736(97)10471-810.1016/S0140-6736(97)10471-8

41.

Yin

R. K.

(2009). Applied social research methods series: Vol. 5. Case study research (4th ed.). Thousand Oaks, CA: Sage.

Participants’ Experiences of Being Debriefed to Placebo Allocation in a Clinical Trial

Abstract

Keywords

Get full access to this article

References